New FDA-approved screening options make colorectal cancer detection easier than ever, with 91% survival rates when caught ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its partnership with actor and ...

March is Colorectal Cancer Awareness Month. A new blood test offers an easier screening option for Tennesseans.

March is National Colorectal Cancer Awareness Month, a reminder that taking care of ourselves isn’t a weakness, but it’s a ...

A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with ...

Guardant Health (NasdaqGS:GH) has launched the Shield Across America mobile screening tour to promote its FDA approved blood test for colorectal cancer. The tour is scheduled to reach more than 100 ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Lagos State govment don begin full investigation into di death of one Nigerian socialite, Nkwopara Elena Jessica wey pipo sabi as "Elena" ...

It’s far easier to authorize military action when someone else’s child bears the risk,” a Boalsburg resident writes.

The future of medicine has arrived, and it brings with it a lot of confusion. From tests to supplements, dietary and exercise advice, it is often difficult to know how to use new medical ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 1:00 PM EDTCompany ParticipantsAmirAli Talasaz - Co-CEO ...